Is Paroxetine (Paxil) safe for dogs and cats?
Moderate risk for petsParoxetine is used off-label in veterinary medicine for canine anxiety, fears, and compulsive disorders; its anticholinergic properties add an additional dimension to toxicity compared to more selective SSRIs. Serotonin syndrome: same clinical presentation as other SSRIs; clinical toxicity threshold approximately 10–20 mg/kg; onset within 1–4 hours. Anticholinergic signs: in addition to serotonin syndrome, paroxetine-toxic dogs may show prominent anticholinergic features — tachycardia, urinary retention, ileus, dry mucous membranes, and pupil dilation; the combined presentation can complicate clinical diagnosis. Short half-life: unlike fluoxetine, paroxetine has a short half-life in dogs; signs may resolve within 12–24 hours with supportive care unless a very large dose was ingested. Treatment: decontamination if early; cyproheptadine for serotonin syndrome; IV fluids; bethanechol may be considered for severe urinary retention; cardiac monitoring for tachycardia. Chronic administration: dogs on paroxetine for behavioral therapy should be slowly tapered before discontinuation to avoid behavioral worsening equivalent to human discontinuation syndrome.
What is paroxetine (paxil)?
The IUPAC name is (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine.
Also known as: (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine, paroxetine, Frosinor, Motivan.
- IUPAC name
- (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
- CAS number
- 61869-08-7
- Molecular formula
- C19H20FNO3
- Molecular weight
- 329.4 g/mol
- SMILES
- C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
- PubChem CID
- 43815
Risk for dogs
Moderate riskParoxetine is used off-label in veterinary medicine for canine anxiety, fears, and compulsive disorders; its anticholinergic properties add an additional dimension to toxicity compared to more selective SSRIs. Serotonin syndrome: same clinical presentation as other SSRIs; clinical toxicity threshold approximately 10–20 mg/kg; onset within 1–4 hours. Anticholinergic signs: in addition to serotonin syndrome, paroxetine-toxic dogs may show prominent anticholinergic features — tachycardia, urinary retention, ileus, dry mucous membranes, and pupil dilation; the combined presentation can complicate clinical diagnosis. Short half-life: unlike fluoxetine, paroxetine has a short half-life in dogs; signs may resolve within 12–24 hours with supportive care unless a very large dose was ingested. Treatment: decontamination if early; cyproheptadine for serotonin syndrome; IV fluids; bethanechol may be considered for severe urinary retention; cardiac monitoring for tachycardia. Chronic administration: dogs on paroxetine for behavioral therapy should be slowly tapered before discontinuation to avoid behavioral worsening equivalent to human discontinuation syndrome.
Regulatory consensus
1 regulatory bodyhas classified Paroxetine (Paxil).
| Agency | Year | Classification | Notes |
|---|---|---|---|
| FDA | — | Pregnancy Category D | Associated with modestly increased risk of cardiac septal defects (ventricular septal defects) when used in first trimester |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where pets encounter paroxetine (paxil)
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Paroxetine (Paxil):
-
Therapeutic alternatives (consult prescriber)
Trade-offs: Drug-specific. Cannot substitute without medical guidance.Relative cost: 1.2-2×
Frequently asked questions
Is paroxetine (paxil) safe for pets?
Paroxetine is used off-label in veterinary medicine for canine anxiety, fears, and compulsive disorders; its anticholinergic properties add an additional dimension to toxicity compared to more selective SSRIs. Serotonin syndrome: same clinical presentation as other SSRIs; clinical toxicity threshold approximately 10–20 mg/kg; onset within 1–4 hours. Anticholinergic signs: in addition to serotonin syndrome, paroxetine-toxic dogs may show prominent anticholinergic features — tachycardia, urinary retention, ileus, dry mucous membranes, and pupil dilation; the combined presentation can complicate clinical diagnosis. Short half-life: unlike fluoxetine, paroxetine has a short half-life in dogs; signs may resolve within 12–24 hours with supportive care unless a very large dose was ingested. Treatment: decontamination if early; cyproheptadine for serotonin syndrome; IV fluids; bethanechol may be considered for severe urinary retention; cardiac monitoring for tachycardia. Chronic administration: dogs on paroxetine for behavioral therapy should be slowly tapered before discontinuation to avoid behavioral worsening equivalent to human discontinuation syndrome.
What products contain paroxetine (paxil)?
Paroxetine (Paxil) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).
See Paroxetine (Paxil) in the pets app
Look up products containing paroxetine (paxil), compare to alternatives, and explore the full data record.
Open in pets View raw API dataSources (2)
- FDA Prescribing Information: Paroxetine (Paxil/Paxil CR) — MDD/OCD/panic/SAD/GAD/PTSD/PMDD; Black Box suicidality; anticholinergic effects; discontinuation syndrome; CYP2D6 inhibitor; Pregnancy Category D cardiac defects; Study 329 controversy; pediatric NOT approved (2023) (2023) — regulatory
- ASPCA Animal Poison Control Center: SSRI/SNRI Toxicosis in Dogs and Cats — serotonin syndrome; cyproheptadine treatment; toxic dose thresholds; fluoxetine/sertraline/paroxetine/escitalopram comparison; clinical signs and management (2023) (2023) — veterinary
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →